Vanguard Capital Management
AYTU icon

Vanguard Capital Management’s AYTU BioPharma AYTU Stock Holding History

Vanguard Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$561K Hold
261,146
– – ﹤0.01% 3698
2026
Q1 		$713K Buy
+261,146
New +$668K ﹤0.01% 3617

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Capital Management's AYTU Position: Q2 2026 in Review

Vanguard Capital Management held its AYTU BioPharma (AYTU) position steady in Q2 2026 at 261,146 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #3698.

Vanguard Capital Management first reported a position in AYTU in Q1 2026 and has held it in 2 quarters since. The position peaked at $713K in Q1 2026. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • Vanguard Capital Management held 261,146 shares of AYTU BioPharma worth $561K as of Q2 2026.
  • Vanguard Capital Management left its AYTU BioPharma share count unchanged in Q2 2026.
  • AYTU BioPharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3698 holding.
  • Vanguard Capital Management first reported a position in AYTU BioPharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's AYTU BioPharma position peaked at $713K in Q1 2026.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.